Budesonide And Formoterol Fumarate Dihydrate
Product Images NDC 53002-2666

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Budesonide And Formoterol Fumarate Dihydrate (NDC 53002-2666). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Counter Image 15 (308708 Rapihaler Counter 15 (black;130;485))

FDA Label Image

Counter Image 80 (308710 Rapihaler Counter 80 (black;130;485))

FDA Label Image

Figure 1 (Figure1bodytext)

FDA Label Image

Figure 2 (Figure2bodytext)

FDA Label Image

Figure 3 (Figure3bodytext)

FDA Label Image

Figure 4 (Figure4bodytext)

This is a graph showing the percent change from baseline in FEV (forced expiratory volume) over a period of 12 hours. It represents the first day of treatment with Budesonide and Formoterol Fumarate Dihydrate, with predose FEV readings for both medications. The final visit (EOT) shows the combination of Budesonide 160 mcg and Formoterol 4.5 mcg, with two inhalations taken twice daily. There is no information regarding the results or effectiveness of the medication.*

FDA Label Image

Figure 5 (Figure5bodytext)

FDA Label Image

Figure 6 (Figure6bodytext)

This is a chart that shows the percent change from baseline in pre-dose FEV for different medications and dosages. The medications include Budescnide and Formoterol Fumarate AL Dibydrato, Budesonide, Formotarol, Budesonide and Formoterol Fumarate Dihydrate MDI, and Flacebo. The dosages vary from 160 to 4.5 mcg, and the administration is two inhalations twice daily.*

FDA Label Image

Figure 7 (Figure7bodytext)

This appears to be a chart showing the percent change from baseline in 1-hour post-dose FEV for different types of inhalations, including Budesonide and Formoterol Fumarate and a placebo. The values differ depending on the type of inhalation and the duration of treatment.*

FDA Label Image

Budesonide Structural Formula (Image 01)

FDA Label Image

Structural Fumarate (Image 02)

FDA Label Image

Figure 1 (Image 03)

The text describes parts of a "Counter" product including a canister for water inside, a mouthpiece, a strap, and a mouthpiece cover. There may be a diagram labeled "Figure 1" with these parts labeled.*

FDA Label Image

Figure 2 Gray Arrows (Image 04)

FDA Label Image

Figure 3 (Image 05)

FDA Label Image

Figure 4 (Image 06)

FDA Label Image

Figure 5 (Image 07)

FDA Label Image

Label Image (Lbl530022666)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.